Disposables for Biopharmaceutical Manufacturing (CQ3426)

Conference Overview

The disposables market is growing by an incredible 20% a year, driven by innovative technical and demand to develop more flexible, cost-effective manufacturing facilities.

Today, nearly 97% of biopharmaceutical manufacturers use single-use technologies. Recent innovations have made a wider range of single-use technologies available for most downstream purification applications and production scales. The aim of this conference is to answer many questions with regards to implementation of this technology. Learn from industry experts and end-users who will share their experience.

KEY SPEAKERS:

  • Dr Paul B. McCormac, Senior Manager Biomanufacturing Sciences Group, Pfizer Global Manufacturing, USA
  • Dr Olivier Cochet, Dir. Industrial Biotechnology, Centre d'Immunologie, Pierre Fabre, France
  • Dr Stephen Brown, Chief Technical Officer, Vivalis, France
  • Dr Wilfried Wöhrer, Director of Pilot Plant Operations, Baxter Innovations GmbH, Austria
  • Dr Emile Van Corven, Director, Process Development, Crucell, The Netherlands and Dr Parrish Galiher, Founder and Chief Technology Officer, Xcellerex, USA
  • Dr Karin Hedebo Wassard,Senior Consultant, NNE Pharmaplan, Denmark and Birgitte Dornonville la Cour, Senior Specialist (QA), Bavarian Nordic A/S, Denmark
  • Dr Aurore Poles, Assistant Scientist: Specialist in New Technologies and Manufacturing Support, Merck Serono Biodevelopment (affiliate of Merck Serono S.A.)
  • Dr Tony Hitchcock, Head of Manufacturing Technologies, Cobra Biomanufactuirng, UK
  • Dr Vibeke Halkjær-Knudsen, Statens Serum Institut, Denmark
  • Mr Pascal Martin, Project Manager – Quality Assurance Department, Merial SAS, France
  • Dr Alexander Herrmann, Director GMP Fermentation Facility, Roche Diagnostic mbH, Germany
  • Dr Jean-Marc Guillaume, Head of Bioprocessing, Research and Development USP Sanofi Pasteur Vaccines, France and Miriam Monge, VP Global Key Accounts, Biopharm Software solutions, France
  • Dr Klaus Hermansen, Senior Specialist, NNE Pharmaplan, Denmark and end user
  • Dr Peter K Watler, Principal Consultant and CTO, Hyde Engineering and Cosnulting Inc., USA
 
Key reasons to attend Informa Life Sciences’ Disposables for Biopharmaceutical Manufacturing conference:
 
·       Industry case studies on Implementing your single use systems from a multi-site network from Pfizer to an almost 100% disposable facility from Pierre Fabre
·       Creating manufacturing flexibility of the future - the use of single-use technology
·      Waste management and environmental assessment- single use solutions versus reusable equipment – from Statens Serum Institut and Merial SAS
·      Baxter will reveal the challenges they encountered when implementing disposables for the production of viral vaccines
·       The comparison of fed batch cell culture performance between stainless steel and single-use bioreactors will be discussed by Merck Serono
 
 
Recommended Workshops

Tuesday 26 October 2010

Workshop T: Extractables, Leachables and Particulates - Safety Concerns for Biotechnology Products

WORKSHOP LEADER
Dr Nanda K. Subbarao, Senior Consultant, Biologics Consulting Group, Inc., USA

Click Here for the full agenda

Friday 29 October 2010

Workshop X: Single Use Versus Stainless Steel impact on Design of Flexible Modular Based Facilities

WORKSHOP LEADER
Klaus Hermansen, Senior Specialist, nne pharmaplan, Denmark & Andrew Sinclair, Biopharm services , UK

Click Here for the full agenda

Workshop Y: Cost Management for Biomanufacturing: The Influence of Development, Design and Engineering

WORKSHOP LEADERS
Bill Thompson, Consultant, Rotherwood Associates, UK

Click Here for the full agenda

 

 

   
Website powered by MicroTidy ™